{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:49:45Z","timestamp":1764996585107,"version":"3.41.2"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"vor","delay-in-days":310,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Medical History Services"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To analyse interrater reliability of four RheuMetric checklist 0\u201310 visual numerical scales (VNSs) of physician global assessment (DOCGL), inflammation or reversible findings (DOCINF), organ damage or irreversible findings (DOCDAM) and patient distress or findings explained by fibromyalgia, depression or anxiety (DOCDIS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A retrospective study was performed of data from a rheumatology fellows\u2019 continuity clinic at Rush University. Each rheumatology patient seen in routine care with any diagnosis completed a multidimensional health assessment questionnaire (MDHAQ). Both the rheumatology fellow and attending rheumatologist independently completed RheuMetric estimates at the same visit for DOCGL, DOCINF, DOCDAM, DOCDIS and the proportion of DOCGL explained by each subglobal estimate (totalling 100%). Agreement between the two assessors was compared using paired t-tests, Spearman correlation coefficients, intraclass correlation coefficients (ICCs), Lin\u2019s concordance correlation coefficients (LCCCs) and Bland\u2013Altman plots.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In 112 patients, mean levels of DOCINF were highest in inflammatory diseases, DOCDAM in osteoarthritis (OA) and DOCDIS in primary fibromyalgia (FM). However, mean DOCDAM was as high as DOCINF in inflammatory diseases. No statistically significant differences were seen between scores from attending rheumatologists and fellows. Agreement within 2\/10 ranged from 60% for DOCGL to 71% for DOICINF and DOCDAM. Spearman correlations were 0.49\u20130.65, ICCs were 0.46\u20130.63 and LCCCs were 0.46\u20130.62 between rheumatologist and fellow, indicating moderate agreement; reliability was slightly higher for each subglobal VNS than for DOCGL.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>RheuMetric 0\u201310 DOCGL, DOCINF, DOCDAM and DOCDIS have moderate interrater reliability and are feasible in routine care to estimate patient status beyond DOCGL for improved management decisions.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rap\/rkae137","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T19:50:39Z","timestamp":1730922639000},"source":"Crossref","is-referenced-by-count":1,"title":["Interrater reliability of RheuMetric checklist scales for physician global assessment, inflammation, damage and patient distress"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5708-5971","authenticated-orcid":false,"given":"Juan","family":"Schmukler","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Rush University Medical Center , Chicago, IL,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1811-2417","authenticated-orcid":false,"given":"Isabel","family":"Castrejon","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Rush University Medical Center , Chicago, IL,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5026-1773","authenticated-orcid":false,"given":"Tengfei","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Rush University Medical Center , Chicago, IL,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel A","family":"Block","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Rush University Medical Center , Chicago, IL,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore","family":"Pincus","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Rush University Medical Center , Chicago, IL,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,11,6]]},"reference":[{"key":"2024121020402080400_rkae137-B1","first-page":"178","article-title":"RheuMetric a physician checklist to record patient levels of inflammation, damage and distress as quantitative data rather than as narrative impressions","volume":"73","author":"Castrejon","year":"2015","journal-title":"Bull Hosp Jt Dis (2013)"},{"issue":"Suppl 107","key":"2024121020402080400_rkae137-B2","first-page":"21","article-title":"A RheuMetric physician checklist to quantitate levels of inflammation, damage and distress on 0-10 visual analogue scales","volume":"35","author":"Castrejon","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"2024121020402080400_rkae137-B3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/acr2.11574","article-title":"RheuMetric quantitative 0 to 10 physician estimates of inflammation, damage, and distress in rheumatoid arthritis: validation against reference measures","volume":"5","author":"Rodwell","year":"2023","journal-title":"ACR Open Rheumatol"},{"key":"2024121020402080400_rkae137-B4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/art.1780360601","article-title":"The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials","volume":"36","author":"Felson","year":"1993","journal-title":"Arthritis Rheum"},{"key":"2024121020402080400_rkae137-B5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3899\/jrheum.081046","article-title":"The uses of disease activity scoring and the physician global assessment of disease activity for managing rheumatoid arthritis in rheumatology practice","volume":"36","author":"Harrington","year":"2009","journal-title":"J Rheumatol"},{"key":"2024121020402080400_rkae137-B6","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/rheumatology\/kep170","article-title":"Depression in RA patients treated with anti-TNF is common and under-recognized in the rheumatology clinic","volume":"48","author":"Hider","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"2024121020402080400_rkae137-B7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/acr2.1006","article-title":"The problematic nature of fibromyalgia diagnosis in the community","volume":"1","author":"Srinivasan","year":"2019","journal-title":"ACR Open Rheumatol"},{"key":"2024121020402080400_rkae137-B8","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s10067-019-04574-6","article-title":"The effect of concomitant hand osteoarthritis on pain and disease activity in patients with rheumatoid arthritis","volume":"38","author":"Ruiz-Medrano","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2024121020402080400_rkae137-B9","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/rheumatology\/key075.533","article-title":"Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis","volume":"57","author":"Duffield","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2024121020402080400_rkae137-B10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/acr2.11514","article-title":"Should quantitative assessment of rheumatoid arthritis include measures of joint damage and patient distress, in addition to measures of apparent inflammatory activity?","volume":"5","author":"Pincus","year":"2023","journal-title":"ACR Open Rheumatol"},{"key":"2024121020402080400_rkae137-B11","doi-asserted-by":"crossref","first-page":"152151","DOI":"10.1016\/j.semarthrit.2022.152151","article-title":"Patient global assessment is elevated by up to 5 of 10 units in patients with inflammatory arthritis who screen positive for fibromyalgia (by FAST4) and\/or depression (by MDS2) on a single MDHAQ","volume":"58","author":"Schmukler","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"2024121020402080400_rkae137-B12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3899\/jrheum.190277","article-title":"Fibromyalgia assessment screening tool: clues to fibromyalgia on a multidimensional health assessment questionnaire for routine care","volume":"47","author":"Gibson","year":"2020","journal-title":"J Rheumatol"},{"key":"2024121020402080400_rkae137-B13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/acr.22108","article-title":"Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity","volume":"66","author":"Tymms","year":"2014","journal-title":"Arthritis Care Res"},{"key":"2024121020402080400_rkae137-B14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/acr.24830","article-title":"Implementing a treat-to-target approach for rheumatoid arthritis during the covid-19 pandemic: results of a virtual learning collaborative program","volume":"74","author":"Solomon","year":"2022","journal-title":"Arthritis Care Res"},{"key":"2024121020402080400_rkae137-B15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.rdc.2019.07.001","article-title":"Treat to target in rheumatology: a historical account on occasion of the 10th anniversary","volume":"45","author":"Smolen","year":"2019","journal-title":"Rheum Dis Clin North Am"},{"key":"2024121020402080400_rkae137-B16","first-page":"1432","article-title":"Further development of a physical function scale on a MDHAQ for standard care of patients with rheumatic diseases","volume":"32","author":"Pincus","year":"2005","journal-title":"J Rheumatol"},{"key":"2024121020402080400_rkae137-B17","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.3899\/jrheum.080182","article-title":"RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories","volume":"35","author":"Pincus","year":"2008","journal-title":"J Rheumatol"},{"key":"2024121020402080400_rkae137-B18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40674-021-00175-0","article-title":"A self-report multidimensional health assessment questionnaire (MDHAQ) for face-to-face or telemedicine encounters to assess clinical severity (RAPID3) and screen for fibromyalgia (FAST) and depression (DEP)","volume":"7","author":"Gibson","year":"2021","journal-title":"Curr Treat Options Rheumatol"},{"key":"2024121020402080400_rkae137-B19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/03009747909105345","article-title":"Clinical assessment of disease activity in rheumatoid arthritis","volume":"8","author":"Hanson","year":"1979","journal-title":"Scand J Rheumatol"},{"key":"2024121020402080400_rkae137-B20","first-page":"661","article-title":"Comparison of four articular indices for use in clinical trials in rheumatoid arthritis: patient, order and observer variation","volume":"18","author":"Thompson","year":"1991","journal-title":"J Rheumatol"},{"key":"2024121020402080400_rkae137-B21","first-page":"892","article-title":"Reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials","volume":"28","author":"Lassere","year":"2001","journal-title":"J Rheumatol"},{"key":"2024121020402080400_rkae137-B22","first-page":"216","article-title":"Limitations of a quantitative swollen and tender joint count to assess and monitor patients with rheumatoid arthritis","volume":"66","author":"Pincus","year":"2008","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"2024121020402080400_rkae137-B23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.rdc.2009.10.004","article-title":"Joint counts to assess rheumatoid arthritis for clinical research and usual clinical care: advantages and limitations","volume":"35","author":"Sokka","year":"2009","journal-title":"Rheum Dis Clin North Am"},{"key":"2024121020402080400_rkae137-B24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1056\/NEJM197510022931405","article-title":"The reliability of clinical methods, data and judgments (second of two parts)","volume":"293","author":"Koran","year":"1975","journal-title":"N Engl J Med"},{"key":"2024121020402080400_rkae137-B25","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","article-title":"Correlation coefficients: appropriate use and interpretation","volume":"126","author":"Schober","year":"2018","journal-title":"Anesth Analg"},{"key":"2024121020402080400_rkae137-B26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"2024121020402080400_rkae137-B27","first-page":"1138","article-title":"Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or American College of Rheumatology criteria for remission","volume":"30","author":"Sokka","year":"2003","journal-title":"J Rheumatol"},{"key":"2024121020402080400_rkae137-B28","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1002\/art.22193","article-title":"Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials","volume":"54","author":"Zink","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2024121020402080400_rkae137-B29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/art.1790100606","article-title":"Measures of activity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over five years","volume":"10","author":"Callahan","year":"1997","journal-title":"Arthritis Care Res"},{"key":"2024121020402080400_rkae137-B30","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1136\/annrheumdis-2020-218744","article-title":"Role of joint damage, malalignment and inflammation in articular tenderness in rheumatoid arthritis, psoriatic arthritis and osteoarthritis","volume":"80","author":"Gessl","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2024121020402080400_rkae137-B31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.61.1.20","article-title":"The rheumatoid arthritis articular damage score: first steps in developing a clinical index of long term damage in RA","volume":"61","author":"Zijlstra","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"2024121020402080400_rkae137-B32","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/ar4163","article-title":"Joint damage in rheumatoid arthritis: assessment of a new scoring method","volume":"15","author":"Pfeil","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2024121020402080400_rkae137-B33","first-page":"492","article-title":"An experiment in reducing interobserver variability of the examination for joint tenderness","volume":"15","author":"Klinkhoff","year":"1988","journal-title":"J Rheumatol"},{"key":"2024121020402080400_rkae137-B34","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/BF02238547","article-title":"Standardising joint assessment in rheumatoid arthritis","volume":"15","author":"Scott","year":"1996","journal-title":"Clin Rheumatol"},{"issue":"5 Suppl 85","key":"2024121020402080400_rkae137-B35","first-page":"S-47","article-title":"Relative efficiencies of the 7 rheumatoid arthritis core data set measures to distinguish active from control treatments in 9 comparisons from clinical trials of 5 agents","volume":"32","author":"Pincus","year":"2014","journal-title":"Clin Exp Rheumatol"}],"container-title":["Rheumatology Advances in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumap\/advance-article-pdf\/doi\/10.1093\/rap\/rkae137\/60453620\/rkae137.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/8\/4\/rkae137\/60964546\/rkae137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/8\/4\/rkae137\/60964546\/rkae137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T21:38:04Z","timestamp":1733866684000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumap\/article\/doi\/10.1093\/rap\/rkae137\/7879346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,9,14]]}},"URL":"https:\/\/doi.org\/10.1093\/rap\/rkae137","relation":{},"ISSN":["2514-1775"],"issn-type":[{"type":"electronic","value":"2514-1775"}],"subject":[],"published-other":{"date-parts":[[2024]]},"published":{"date-parts":[[2024]]},"article-number":"rkae137"}}